Summit Therapeutics Shares Resumed Trading. Co Raised $200M Via Institutional Offering of 22.2M Shares at $9/Share for Clinical Development of Ivonescimab
Summit Therapeutics Shares Resumed Trading. Co Raised $200M Via Institutional Offering of 22.2M Shares at $9/Share for Clinical Development of Ivonescimab
summit therapeutics股票恢復交易。公司以每股9美元的價格發行2220萬股機構配售股票，籌得2億美元用於ivonescimab的臨牀開發。
Summit Therapeutics Shares Resumed Trading. Co Raised $200M Via Institutional Offering of 22.2M Shares at $9/Share for Clinical Development of Ivonescimab
summit therapeutics股票交易已經恢復。公司通過以每股9美元的價格發行22.2百萬股份的機構配售融資2億美元，用於ivonescimab的臨床開發。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。